What is a research peptide?

What does “for research use only, not for human use” mean?

This wording is a statement placed on the label by the party selling the product; it does not show that any authority has examined the product. The real question is how the product is actually presented.

The FDA makes a clear finding on this: it has warned companies that illegally sell unapproved drugs containing semaglutide, tirzepatide, retatrutide, survodutide, or mazdutide and falsely labeled “for research purposes” or “not for human consumption.” According to the FDA, these products were sold directly to consumers, for human use, with dosing instructions; the FDA asks consumers not to buy these products, whose quality is unknown and which may be harmful to health. ^[1]

The way sellers present products has been examined in detail in one study. In the study by a Hungary-based team that examined illegal online sellers of semaglutide without a prescription, vial labels and company logos gave a laboratory-focused appearance, and the labels read “for research use only.” Even so, most product descriptions described health benefits of GLP-1 agonists such as weight loss and diabetes, and one of three powder sellers gave instructions for preparing the freeze-dried powder (the other two did not). One site asked the customer to confirm a statement agreeing that the products were “not for human or animal use.” The authors write that “99% purity at research grade” and pharmaceutical quality are markedly different from each other and that consumers may be misled by these statements. ^[2]

In short, the label does not change the fact that the product is marketed for human use; it leaves the product outside the quality, safety, and efficacy assessment that a medicine must carry.

Why does the gray market use this label?

A licence is required for a substance to be sold as a medicine. In Türkiye, Article 3 of Law No. 1262 (Law No. 1262 on Pharmaceutical and Medicinal Preparations; İspençiyari ve Tıbbi Müstahzarlar Kanunu) requires Ministry permission before domestically produced medicinal preparations are placed on the market and before those produced abroad are imported. ^[7] The “for research use only” label presents the product not as a medicine but as a laboratory chemical: the sellers examined by Ashraf and colleagues declared, while describing the health benefits of the products, that the unbranded “laboratory products” were for research purposes only and not suitable for human use. ^[2] The FDA’s assessment above shows that when the label and the actual marketing do not match, the authority treats the product as an unapproved drug. ^[1]

Another consequence of this label is that quality assurance disappears completely. According to the FDA, unapproved products are not reviewed for safety, efficacy, and quality before they reach the market ^[1]; in a “research” product, content, purity, and sterility have not been independently verified. The storage conditions on the label of licensed products are described in the How are peptides stored? guide.

How does it differ from a drug used in clinical trials?

The word “research” is misleading, because the product used in a real clinical trial is subject to strict rules. In Türkiye and the EU, these rules are defined by regulation.

In the US as well, the organization developing a drug must, before starting a clinical trial, submit to the FDA an application (IND) containing animal study and toxicity data, manufacturing information, and study protocols. ^[11] A vial sold online being “for research use” does not mean it has gone through any of these processes.

What was found in tested products?

The content of gray-market peptides has been measured in several independent analyses. The scope of each study differs, and the results may not represent the whole market.

This report from the Norwegian doping control laboratory states that some peptide drugs are produced illegally and in some cases reach the public without entering or completing clinical trials; the authors note that CJC-1295 is on the WADA prohibited list because of its growth hormone-releasing effect and that there is reason to think it is used in bodybuilding circles. ^[3] The analysis of products sold as retatrutide in Australia is described in the Retatrutide guide.

Why are sterility and endotoxin separate things?

Sterility means that no live microorganisms are present in the product. Endotoxin, on the other hand, is residue from the cell wall of Gram-negative bacteria and can be present even if the product is sterile. The study by Ashraf and colleagues shows this difference concretely: there were no live microorganisms in the vials at the time of testing, but endotoxin was found in all three, and the authors interpret this as a sign of possible contamination during manufacture. ^[2] In a product used by injection, each carries a separate risk; being sold as a “freeze-dried powder” does not remove these risks.

How do social media and “influencer” marketing work?

The EMA and the EU Heads of Medicines Agencies (HMA) announced in September 2025 a sharp rise in illegal medicines marketed as GLP-1, saying these products are mostly sold through fake websites and social media. The authorities identified hundreds of fake Facebook profiles, advertisements, and e-commerce listings; some sites and advertisements were reported to misuse official logos and mislead consumers with fake endorsements. According to the EMA, a claim that a product is “approved” by a national authority, or a claim that it is superior to authorized treatments without scientific evidence, is among the warning signs of illegality. ^[5]

A 2026 narrative review writes that online “biohacking” and wellness circles promote experimental or weakly evidenced peptides for fat burning, recovery, aesthetics, cognitive performance, and longevity; and that digital promotion, gray-market access, self-injection, using multiple peptides together (“stacking”), informal dose escalation, and uncertainty about product quality together normalize a use outside clinical oversight that is hard to monitor. According to the authors, the real problem is not legitimate peptide drugs but consumer experiments with products of uncertain identity, purity, potency, sterility, and safety. ^[6]

What is the legal status of research peptides in Türkiye?

• Licence: In TİTCK’s Licensed Human Medicinal Products List dated October 16, 2026, there is no product containing BPC-157, TB-500, GHK-Cu, CJC-1295, ipamorelin, epitalon, MOTS-c, selank, or semax; retatrutide is not on the list either. ^[8]
• Permission requirement: Article 3 of Law No. 1262 makes the marketing and import of preparations subject to Ministry permission. ^[7]
• Penalty: Article 19 of the same Law provides for imprisonment of one to five years for those who manufacture unlicensed preparations and for those who knowingly sell them, offer them for sale, or have them sold; if it is found that the preparation was made from impure substances, the penalty is increased by one third. Selling, marketing, or advertising a product with a claim that it diagnoses or treats diseases is also punished even if it is not a preparation; if promotion or sale is done over the internet, a decision to block access is made. ^[7]

The position of a particular product labeled “for research use” in relation to these provisions is assessed by the administration and the courts according to the specific case; this page is not legal advice. The general legal status of peptides is addressed in the Are peptides legal? guide.

How is a real clinical study read?

A claim of “proven in clinical studies” can be tested by checking a study’s registration and phase. In publicly accessible registry systems such as ClinicalTrials.gov, each study shows a registration number (beginning with NCT in the US registry), its phase, number of participants, status (ongoing, completed, terminated), and published results if any. The FDA defines the phases as follows: ^[11]

According to the FDA, about 70% of drugs move from phase 1 to phase 2, about 33% from phase 2 to phase 3, and about 25–30% beyond phase 3; phase 2 studies are not large enough to show whether a drug is beneficial. ^[11] A substance having animal studies or a single small human study does not mean it is “clinically proven.” On this site, the evidence for each research peptide is evaluated separately according to its type and phase:

Where to go after this guide?

The general definition of peptides is on the What are peptides? page, their types on Types of peptides, and side effects on Peptide side effects; licensed GLP-1 drugs are covered in the What is GLP-1? and GLP-1 agonists guides; how long a substance stays in the body is covered in the What does half-life mean? guide. This guide gives no information on the procurement, preparation, dose, or use of any product.